Inventor · disambiguated record
Susan L. Way
Also filed as: WAY SUSAN · WAY SUSAN L · WAY SUSAN LYNN
3 granted patents·11 pending applications·12 citations·filing 2001–2025
63Inventor score
Files withACORDA THERAPEUTICS INC7BOEHRINGER INGELHEIM PHARMA4BOEHRINGER INGELHEIM FRANCE1MERZ PHARMACEUTICALS LLC1SIMIANER STEFAN1
Top patents by PatentIndex Score
14 records- 0171US2024050376A1Sustained release compositions of 4-aminopyridineACORDA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0270US12029820B2Sustained release compositions of 4-aminopyridineACORDA THERAPEUTICS INC·Filed 2021·Granted Jul 9, 2024·0 cites·32 claims
- 0370US6808721B2Methods for coating pharmaceutical core tabletsBOEHRINGER INGELHEIM PHARMA·Filed 2002·Granted Oct 26, 2004·4 cites·12 claims
- 0470US6565880B2Oral dosage formulations of 1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)-naphthalen-1-yl]-ureaBOEHRINGER INGELHEIM PHARMA·Filed 2001·Granted May 20, 2003·8 cites·18 claims
- 0565US2025248942A1Sustained Release Compositions of 4-AminopyridineMERZ PHARMACEUTICALS LLC·Filed 2025·Application pending·0 cites
- 0664US2021085614A1Sustained release compositions of 4-aminopyridineACORDA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0763US2022323362A1Sustained release compositions of 4-aminopyridineACORDA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0862US2020253880A1Sustained release compositions of 4-aminopyridineACORDA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0958US2018344649A1Sustained release compositions of 4-aminopyridineACORDA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 1054US2020108016A1Sustained release compositions of 4-aminopyridineACORDA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1147US2007099832A1Combination Therapy with p38 MAP Kinase Inhibitors and their Pharmaceutical CompositionsSIMIANER STEFAN·Filed 2006·Application pending·0 cites
- 1246US2004110755A1Combination therapy with p38 MAP kinase inhibitors and their pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Application pending·0 cites
- 1346US2003068340A1Parenteral formulations of 1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)-naphthalen-1-yl]-ureaBOEHRINGER INGELHEIM PHARMA·Filed 2002·Application pending·0 cites
- 1437US2005148555A1Methods of treating COPD and pulmonary hypertensionBOEHRINGER INGELHEIM FRANCE·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Susan L. Way files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →